Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir to Reduce Mother-to-Infant HBV Transmission
NCT01312012Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2011
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in hepatitis B (HBV), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01312012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01312012.